A nasal spray developed by researchers from Chulalongkorn University which could lessen the risk of catching Covid-19 will be available for the public to purchase starting upon Oct 1 .
The aerosol, which will be sold beneath the brand name “VAILL CITITRAP Anti-Cov Nasal Spray”, is produced by Hibiocy, a subsidiary of the cosmetics conglomerate Rojukiss International.
Developed by a group of doctors plus researchers from Chulalongkorn University’s Faculty of Medicine, the aerosol is truly a Thai innovation for Thai people, said Rojukiss CEO Worawarn Chaikamnerd.
A newly developed anti-Covid nasal aerosol is launched and is now available for industrial sale. Apichart Jinakul
The spray is designed to coat the customer’s nasal cavities using a layer of hydroxypropyl methylcellulose, which provides a physical barrier in the virus. It can be used every six hrs, up to three times a day.
More information can be obtained on Line by adding @Covitrap, Facebook as well as through pharmacists at the Federal government Pharmaceutical Organization’s drugstores and clinics, the girl said.
Nopporn Chuenklin, movie director of the Health Program Research Institute (HSRI), praised the patented product, calling it a superb Thai innovation.